Reference:
1. Enriquez-Sarano M, Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a public health crisis. Prog Cardiovasc Dis. 2019;62:447-451.
2. Yang L, Chen H, Pan W, et al. Analyses for Prevalence and Outcome of Tricuspid Regurgitation in China: An Echocardiography Study of 134,874 Patients. Cardiology. 2019;142:40-46.
3. Benfari G, Antoine C, Miller WL, et al. Excess Mortality Associated With Functional Tricuspid Regurgitation Complicating Heart Failure With Reduced Ejection Fraction. Circulation. 2019;140:196-206.
4. Topilsky Y, Inojosa JM, Benfari G, et al. Clinical presentation and outcome of tricuspid regurgitation in patients with systolic dysfunction. Eur Heart J. 2018;39:3584-3592.
5. Kazum SS, Sagie A, Shochat T, et al. Prevalence, Echocardiographic Correlations, and Clinical Outcome of Tricuspid Regurgitation in Patients with Significant Left Ventricular Dysfunction. Am J Med. 2019;132:81-87.
6. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2438-2488.
7. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;38:2739-2791.
8. Farber G, Tkebuchava S, Dawson RS, et al. Minimally Invasive, Isolated Tricuspid Valve Redo Surgery: A Safety and Outcome Analysis. Thorac Cardiovasc Surg. 2018;66:564-571.
9. Wang Q, Xue X, Yang J, et al. Right mini-thoracotomy approach reduces hospital stay and transfusion of mitral or tricuspid valve reoperation with non-inferior efficacy: evidence from propensity-matched study. J Thorac Dis. 2018;10:4789-4800.
10. Lu S, Song K, Yao W, et al. Simplified, minimally invasive, beating-heart technique for redo isolated tricuspid valve surgery. J Cardiothorac Surg. 2020;15:146.
11. Chen Z, Ke Y, Xie X, et al. Outcomes of Totally Endoscopic Beating-Heart Tricuspid Repair in Redo Cardiac Surgery. Heart Lung Circ. 2020:1443-9506.
12. He BC, Ke YJ, Zhou K, et al. Modified unicaval drainage in reoperative isolated tricuspid valve repair via totally thoracoscopic approach. Perfusion. 2020;35:649-657.
13. Chen Z, Ke Y, Xie X, et al. Beating-Heart Totally Endoscopic Tricuspid Valvuloplasty in Reoperative Cardiac Surgery. Ann Thorac Surg. 2019;107:e79-e82.
14. Zack CJ, Fender EA, Chandrashekar P, et al. National Trends and Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol. 2017;70:2953-2960.
15. Bevan PJW, Haydock DA, Kang N. Long-term Survival after Isolated Tricuspid Valve Replacement. Heart Lung Circ. 2014;23:697-702.
16. Buzzatti N, Iaci G, Taramasso M, et al. Long-term outcomes of tricuspid valve replacement after previous left-side heart surgery. Eur J Cardiothorac Surg. 2014;46:713-719.
17. Oh TH, Wang TK, Sidhu K, et al. Isolated tricuspid valve surgery at a single centre: the 47-year Auckland experience, 1965-2011. Interact Cardiovasc Thorac Surg. 2014;18:27-32.
18. Chen J, Hu K, Ma W, et al. Isolated reoperation for tricuspid regurgitation after left-sided valve surgery: technique evolution. Eur J Cardiothorac Surg. 2020;57:142-150.
19. Bashore TM, Serfas JD. Isolated Tricuspid Valve Surgery. J Am Coll Cardiol. 2017;70:2961-2963.
20. Axtell AL, Bhambhani V, Moonsamy P, et al. Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation. J Am Coll Cardiol. 2019;74:715-725.
21. Chen JM, Abudupataer M, Hu K, et al. Risk factors associated with perioperative morbidity and mortality following isolated tricuspid valve replacement. J Surg Res. 2018;221:224-231.
22. Topilsky Y, Khanna AD, Oh JK, et al. Preoperative factors associated with adverse outcome after tricuspid valve replacement. Circulation. 2011;123:1929-1939.
Table 1. Preoperative Data